NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE234885 Query DataSets for GSE234885
Status Public on Jun 13, 2024
Title Sorafenib inhibits invasion of multicellular organoids that mimic Lymphangioleiomyomatosis nodules.
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Lymphangioleiomyomatosis (LAM) is a debilitating, progressive lung disease with few therapeutic options, largely due to a paucity of mechanistic knowledge of disease pathogenesis. Lymphatic endothelial cells (LECs) are known to envelope and invade clusters of LAM-cells, comprising of smooth muscle α-actin and/or HMB-45 positive "smooth muscle-like cells” however the role of LECs in LAM pathogenesis is still unknown. To address this critical knowledge gap, we investigated wether LECs interact with LAM-cells to augment their metastatic behaviour of LAM-cells. We performed in situ spatialomics and identified a core of transcriptomically related cells within the LAM nodules. Pathway analysis highlights wound and pulmonary healing, VEGF signaling, extracellular matrix/actin cytoskeletal regulating and the HOTAIR regulatory pathway enriched in the LAM Core cells. We developed an organoid co-culture model combining primary LAM-cells with LECs and applied this to evaluate invasion, migration, and the impact of Sorafenib, a multi-kinase inhibitor. LAM-LEC organoids had significantly higher extracellular matrix invasion, decreased solidity and a greater perimeter, reflecting increased invasion compared to non-LAM control smooth muscle cells. Sorafenib significantly inhibited this invasion in both LAM spheroids and LAM-LEC organoids compared to their respective controls. We identified TGFβ1ι1, a molecular adapter coordinating protein-protein interactions at the focal adhesion complex and known to regulate VEGF, TGFβ and Wnt signalling, as a Sorafenib-regulated kinase in LAM-cells. In conclusion we have developed a novel 3D co-culture LAM model and have demonstrated the effectiveness of Sorafenib to inhibit LAM-cell invasion, identifying new avenues for therapeutic intervention.
 
Overall design Spatial Transcriptome sequencing libraries were prepared with 10x Genomic Visium Spatial Gene Expression Slides & reagent kit according to the manufacturers instructions
 
Contributor(s) Ryan AL, Koc-Gunel S, Gautam LK, Calvert BA, Murthy S, Harriott NC, Nawroth JC, Zhou B, Krymskaya VP
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jun 14, 2023
Last update date Jun 13, 2024
Contact name Amy Leanne Ryan
E-mail(s) amy-l-ryan@uiowa.edu
Phone 13193358908
Organization name The University of Iowa
Department Anatomy and Cell Biology
Lab Ryan Laboratory
Street address 51 Newton Road
City Iowa City
State/province IA
ZIP/Postal code 52242-1009
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (2)
GSM7476184 LAM Donor Region 1
GSM7476185 LAM Donor Region 2
Relations
BioProject PRJNA983678

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE234885_RAW.tar 8.3 Gb (http)(custom) TAR (of CLOUPE, CSV, H5, JPG, JSON, PNG)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap